Target's General Information
Target ID T86652
Target Name PCSK9 messenger RNA (PCSK9 mRNA)
Synonyms Subtilisin/kexin-like protease PC9 (mRNA); Proprotein convertase subtilisin/kexin type 9 (mRNA); Proprotein convertase 9 (mRNA); PSEC0052 (mRNA); PC9 (mRNA); Neural apoptosis-regulated convertase 1 (mRNA); NARC1 (mRNA); NARC-1 (mRNA)
Target Type Successful
Gene Name PCSK9
Biochemical Class mRNA target
UniProt ID PCSK9_HUMAN
Target's Expression Profile in Disease Related Tissue between Patients and Normal People
Disease Coronary artery disease
Example drug BMS-PCSK9 Preclinical [1], [2]
Tissue Peripheral blood
Level of differential expression between the patients in the disease section of the tissue and the tissues of healthy individual Fold-change: -0.13
Z-score: -0.62
P-value: 9.13E-01
Target gene expression profiles of the patients in the disease section of the tissue
Target gene expression profiles in the tissue of healthy individual
Disease Familial hypercholesterolemia
Example drug ALN-PCS Preclinical [2], [3]
Tissue Whole blood
Level of differential expression between the patients in the disease section of the tissue and the tissues of healthy individual Fold-change: -0.07
Z-score: -0.3
P-value: 4.82E-02
Target gene expression profiles of the patients in the disease section of the tissue
Target gene expression profiles in the tissue of healthy individual
References
REF 1 Clinical pipeline report, company report or official report of ISIS Pharmaceuticals (2011).
REF 2 NCBI GEO: archive for functional genomics data sets--update. Nucleic Acids Res. 2013 Jan;41(Database issue):D991-5.
REF 3 Clinical pipeline report, company report or official report of Alnylam Pharmaceuticals, Inc (2011).

If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.